[1] 李健,马麒.胃癌影响因素研究进展[J].实用肿瘤学杂志,2020,34(5):466-470.
LI J,MA Q.Progress in the study of factors affecting gastric cancer[J].Journal of Practical Oncology,2020,34(5):466-470.
[2] 马江磊,李晓瑶,赵世富,等.胃癌临床分期诊断方法的应用进展[J].上海交通大学学报:医学版,2021,41(06):821-825.
MA JL,LI XY,ZHAO SF,et al.Progress in the application of clinical staging diagnostic methods for gastric cancer[J].Journal of Shanghai Jiaotong University:Medical Edition,2021,41(06):821-825.
[3] 顾鹏飞,邓靖宇,梁寒.胃癌术前分期研究进展[J].中国肿瘤临床,2019,46(1):6-11.
GU PF,DENG JY,LIANG H.Advances in preoperative staging of gastric cancer[J].Chinese Oncology Clinics,2019,46(1):6-11.
[4] YAMADA K,URAKAWA N,KANAJI S et al.Preoperative prediction of the pathological stage of advanced gastric cancer by F-fluoro-2-deoxyglucose positron emission tomography[J].Scientific Reports,2022,12(1):11370.
[5] 王华涛,赵葵,张亚飞,等.胃充盈状态对18F-FDG PET/CT图像质量的影响[J].临床放射学杂志,2019,38(12):2425-2428.
WANG HT,ZHAO K,ZHANG YF,et al.Effect of gastric filling status on 18F-FDG PET/CT image quality[J].Journal of Clinical Radiology,2019,38(12):2425-2428.
[6] DIAS AH,HANSEN AK,MUNK OL,et al.Normal values for 18F-FDG uptake in organs and tissues measured by dynamic whole body multiparametric FDG PET in 126 patients[J].EJNMMI Research,2022,12(1):15-28.
[7] YOON JK,BYUN C,JO KS,et al.Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using 18F-FDGPET[J].Medicine,2019,98(31):e16690.
[8] PIETRZAK AK,KAMIERSKA J,MARSZAEK A,et al.Dual-time-point PET/CT study protocol can improve the larynx cancer diagnosis[J].Reports of Practical Oncology and Radiotherapy,2020,25(4):533-538.
[9] 任春玲.双时相18F-FDG PET/CT显像在膀胱癌诊断中的应用价值分析[J].影像研究与医学应用,2021,5(11):117-118.
REN CL.Analysis of the application value of dual-phase 18F-FDG PET/CT imaging in the diagnosis of bladder cancer[J].Imaging Research and Medical Application,2021,5(11):117-118.
[10] PANG L,BO X,WANG J,et al.Role of dual-time point 18F-FDG PET/CT imaging in the primary diagnosis and staging of hilar cholangiocarcinoma[J].Abdominal Radiology,2021,46(9):4138-4147.
[11] EL-KHOLYESRAA,KHALED LOBNA.Diagnostic accuracy of dual-time-point fluorodeoxyglucose-positron emission tomography/computed tomography in verification local recurrence in pancreatic cancer patients[J].Indian J Nucl Med,2019,34:271-277.
[12] TOPI,SANTACROCE,BOTTALICO,et al.Gastric cancer in history:A perspective interdisciplinary study[J].Cancers,2020,12(2):264-277.
[13] 左卫,王全师.18F-FDGPET/CT显像对胃癌的诊断价值及对临床决策的影响[J].实用医学杂志,2015,31(1):39-42.
ZUO W,WANG QS.Diagnostic value of 18F-FDGPET/CT imaging for gastric cancer and its impact on clinical decision making[J].Journal of Practical Medicine,2015,31(1):39-42.
[14] 周海中,于明明,段洁,等.18F-FDG PET/CT显像在胃癌诊断中的应用[J].肿瘤学杂志,2012,18(10):738-739.
ZHOU HZ,YU MM,DUAN J,et al.The application of 18F-FDG PET/CT imaging in the diagnosis of gastric cancer[J].Journal of Oncology,2012,18(10):738-739.
[15] CUI J,ZHAO P,REN Z,et al.Evaluation of dual time point imaging 18F-FDG PET/CT in differentiating malignancy from benign gastric disease[J].Medicine,2015,94(33):e1356.
[16] 许秀霞,程娟,徐文贵,等.18F-脱氧葡萄糖正电子发射断层-X线计算机体层成像双时相显像在胃肠道良恶性病变鉴别诊断中的价值[J].中华肿瘤杂志,2012,34(5):364-368.
XU XX,CHENG J,XU WG,et al.Value of dual-time-point 18F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases[J].Chinese Journal of Oncology,2012,34(5):364-368.
[17] ZHUANG H,POURDEHNAD M,LAMBRIGHT ES,et al.Dual time point 18F-FDG PET Imaging for differentiating malignant from inflammatory processes[J].Journal of Nuclear Medicine,2001,42(9):1412-1417.
[18] SUZUKI S,TOYOTA T,SUZUKI H,et al.Partial purification from human mononuclear cells and placental plasma membranes of an insulin mediator which stimulates pyruvate dehydrogenase and suppresses glucose-6-phosphatase[J].Archives of Biochemistry & Biophysics,1984,235(2):418-426.
[19] DBIEC K,J WYDMANSKI,D'AMICO A,et al.The application of 18F-FDG-PET/CT in gastric cancerstaging and factors affecting its sensitivity[J].Hellenic Journal of Nuclear Medicine,2021,24(1):66-74.
[20] ALAKUS H,BATUR M,SCHMIDT M,et al.Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression[J].Nuclear Medicine Communications,2010,31(6):532-538.
[21] LUEBKE T,BALDUS SE,GRASS G,et al.Histologicalgrading in gastric cancer by Ming classification:Correlation with histopathological subtypes,metastasis,and prognosis[J].World Journal of Surgery,2012,29(11):1422-1427.